Efficacy and Safety of Gefitinib Plus Pemetrexed/Platinum in Advanced EGFR-Mutated Lung Adenocarcinoma Patients: A Real-World Observational Study [Retraction]

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Retraction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584779/
https://www.ncbi.nlm.nih.gov/pubmed/36275182
http://dx.doi.org/10.2147/OTT.S394058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584779/
https://www.ncbi.nlm.nih.gov/pubmed/36275182
http://dx.doi.org/10.2147/OTT.S394058

Ejemplares similares